NZ513416A - Pill dough formulation - Google Patents

Pill dough formulation

Info

Publication number
NZ513416A
NZ513416A NZ51341602A NZ51341602A NZ513416A NZ 513416 A NZ513416 A NZ 513416A NZ 51341602 A NZ51341602 A NZ 51341602A NZ 51341602 A NZ51341602 A NZ 51341602A NZ 513416 A NZ513416 A NZ 513416A
Authority
NZ
New Zealand
Prior art keywords
dough
pill
dough formulation
medicament
pill dough
Prior art date
Application number
NZ51341602A
Inventor
Wayne Frederick Leech
Majid Hameed Abdul Razzak
Patrick Joseph Silcock
Original Assignee
Bomac Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Lab Ltd filed Critical Bomac Lab Ltd
Priority to NZ51341602A priority Critical patent/NZ513416A/en
Publication of NZ513416A publication Critical patent/NZ513416A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

An edible dough for use in an oral delivery system is disclosed, wherein the dough comprises at least one flour; at least one soluble fibre including at least one gum; and at least one other pharmaceutically and or physiologically acceptable agent including at least glycerol; and wherein the dough is capable of being mounted around a medicament selected from the group including: a pill; pills; a capsule; capsules; a tablet; tablets; and combinations thereof; and further characterised in that the dough has extensibility characteristics that allow it to form a film with the medicament.
NZ51341602A 2002-07-09 2002-07-09 Pill dough formulation NZ513416A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ51341602A NZ513416A (en) 2002-07-09 2002-07-09 Pill dough formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ51341602A NZ513416A (en) 2002-07-09 2002-07-09 Pill dough formulation

Publications (1)

Publication Number Publication Date
NZ513416A true NZ513416A (en) 2004-04-30

Family

ID=32501617

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ51341602A NZ513416A (en) 2002-07-09 2002-07-09 Pill dough formulation

Country Status (1)

Country Link
NZ (1) NZ513416A (en)

Similar Documents

Publication Publication Date Title
BG66095B1 (en) Pregelatinized starch in a controlled release preparation
US20090202635A1 (en) Delivery System, Application, and Method
MY125766A (en) Flash-melt oral dosage formulation
WO2003066029A3 (en) Pharmaceutical dosage form for mucosal delivery
WO2003066030A3 (en) Pharmaceutical tablet
AR022672A1 (en) A PHARMACEUTICAL COMPOSITION IN THE FORM OF TABLETS OR CAPSULES THAT CONSTITUTE AN ORAL ADMINISTRATION METHOD OF A DRUG
WO2001032183A3 (en) Pharmaceutical compositions comprising oxcarbazepine
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
RS20090134A (en) Pharmaceutical combinattion of ethinylestradiol and drospinenone for use as a contraceptive
HUP0402154A2 (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
HK1081865A1 (en) Popping oral administration form
EP0966966A3 (en) Nefazodone dosage form
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
WO2008142572A3 (en) Controlled release tablet formulation containing magnesium aluminometasilicate
RU2153337C2 (en) Paracetamol and domperidone tablet with film coating
MY127350A (en) Flash-melt oral dose formulations
Ubhe et al. A brief overview on tablet and it’s types
WO1998038983A3 (en) Swallow tablet comprising paracetamol
EP3130334A1 (en) Controlled-release solid preparation with partial coating
MXPA04003346A (en) Flashmelt oral dosage formulation.
ATE401075T1 (en) MEDICINAL PRODUCT CONTAINING CYTISINE
WO2005004860A3 (en) Novel solid pharmaceutical composition comprising amisulpride
CA2612044C (en) Emetic embedded capsule
WO2008079343A3 (en) Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: BAYER NEW ZEALAND LIMITED, NZ

Free format text: OLD OWNER(S): BOMAC RESEARCH LIMITED

LAPS Patent lapsed